FDA’s Breakthrough Designation Now Includes Health Equity Provision
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Building a Home for Health Equity
The laboratory’s role in reaching underserved patient populations: an interview with Richard Levenson, Keisuke Nakagawa, and Michele Mitchell
Bringing the Lab to the Patients
Actions clinical laboratories can take to better reach underserved communities, raise the lab’s profile, and increase health equity for all
Testosterone Testing Rises with DTC Ads
From - Diagnostic Testing & Emerging Technologies
Televised direct-to-consumer advertising (DTCA) is associated with greater testosterone testing, according to a study published March 21 in the Journal of the American Medical Association…
Biomarkers Personalize PSA Screening
From - Diagnostic Testing & Emerging Technologies
Early diagnosis of prostate cancer (PCa) is marred by a lack of consensus on the best screening strategy. Prostate specific antigen (PSA) had been…
iSpecimen Generates New Market for Discarded Biospecimens
From - Diagnostic Testing & Emerging Technologies
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built…
Do No Harm: Diagnostic Errors and the Lab
By Jennifer (McMahon) Dawson, MHA, DLM (ASCP) bio
"Do no harm" is the mantra that health care providers live by. Doctors, nurses and laboratory professionals alike enter into the business of health care because they are motivated to…
Blood Test Could Improve CAD Diagnosis
From - Diagnostic Testing & Emerging Technologies
A simple blood test can accurately, noninvasively, and quickly diagnose heart disease, according to a study published in the…
Genomic Markers May ID Risk of Chemo Side Effects
From - Diagnostic Testing & Emerging Technologies
While much attention is focused on using genomic markers to target the effectiveness of treatments, simultaneous research is exploring use of genomic markers to…
Screening Test Use Up After ACA
From - Diagnostic Testing & Emerging Technologies
There was an uptick in preventive screening after enactment of the Affordable Care Act (ACA), yet cancer-screening rates in the United States remain below…
